AACT Fundamental Analysis - ARES ACQUISITION CORP II

Fundamental Rating

Overall AACT gets a fundamental rating of 1 out of 10. We evaluated AACT against 0 industry peers in the Unkown industry. Both the profitability and financial health of AACT have multiple concerns. AACT is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

AACT had positive earnings in the past year.

AACT had a negative operating cash flow in the past year.

1.2 Ratios

		Industry Rank	Sector Rank
ROA	2.91%
ROE	3.06%
ROIC	N/A

ROA(3y)2.64%

ROA(5y)N/A

ROE(3y)2.76%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

AACT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for AACT remains at a similar level compared to 1 year ago.

Compared to 1 year ago, AACT has an improved debt to assets ratio.

2.2 Solvency

AACT has an Altman-Z score of 12.91. This indicates that AACT is financially healthy and has little risk of bankruptcy at the moment.

AACT has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.

		Industry Rank	Sector Rank
Debt/Equity	0.02
Debt/FCF	N/A
Altman-Z	12.91

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

AACT has a Current Ratio of 0.23. This is a bad value and indicates that AACT is not financially healthy enough and could expect problems in meeting its short term obligations.

A Quick Ratio of 0.23 indicates that AACT may have some problems paying its short term obligations.

		Industry Rank	Sector Rank
Current Ratio	0.23
Quick Ratio	0.23

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for AACT have decreased strongly by -42.98% in the last year.

EPS 1Y (TTM)-42.98%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-94.97%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 36.50 indicates a quite expensive valuation of AACT.

AACT's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.17.

		Industry Rank	Sector Rank
PE	36.5
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for AACT!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ARES ACQUISITION CORP II

NYSE:AACT (9/24/2025, 8:04:00 PM)

After market: 9.81 +0.32 (+3.37%)

9.49

+0.61 (+6.87%)

Chartmill FA Rating

GICS SectorN/A

GICS IndustryGroupN/A

GICS IndustryN/A

Earnings (Last)08-04 2025-08-04

Earnings (Next)11-10 2025-11-10

Inst OwnersN/A

Inst Owner Change0%

Ins OwnersN/A

Ins Owner Change100%

Market Cap587.05M

Revenue(TTM)N/A

Net Income(TTM)16.33M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	36.5
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	1.1
P/tB	1.1
EV/EBITDA	N/A

EPS(TTM)0.26

EY2.74%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.04

FCFYN/A

OCF(TTM)-0.04

OCFYN/A

SpS0

BVpS8.63

TBVpS8.63

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	2.91%
ROE	3.06%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)2.64%

ROA(5y)N/A

ROE(3y)2.76%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.02
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.23
Quick Ratio	0.23
Altman-Z	12.91

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-42.98%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-94.97%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-457.03%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y31.25%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y31.25%

OCF growth 3YN/A

OCF growth 5YN/A

ARES ACQUISITION CORP II / AACT FAQ

What is the fundamental rating for AACT stock?

ChartMill assigns a fundamental rating of 1 / 10 to AACT.

What is the valuation status for AACT stock?

ChartMill assigns a valuation rating of 0 / 10 to ARES ACQUISITION CORP II (AACT). This can be considered as Overvalued.

How profitable is ARES ACQUISITION CORP II (AACT) stock?

ARES ACQUISITION CORP II (AACT) has a profitability rating of 0 / 10.

What is the valuation of ARES ACQUISITION CORP II based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ARES ACQUISITION CORP II (AACT) is 36.5 and the Price/Book (PB) ratio is 1.1.

ARES ACQUISITION CORP II (AACT) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

ARES ACQUISITION CORP II / AACT FAQ

What is the fundamental rating for AACT stock?

What is the valuation status for AACT stock?

How profitable is ARES ACQUISITION CORP II (AACT) stock?

What is the valuation of ARES ACQUISITION CORP II based on its PE and PB ratios?